Navigation Links
Intravenous (IV) Administration of Cempra Pharmaceutical's Solithromycin (CEM-101) Demonstrates Excellent Systemic Tolerability in a Phase 1 Clinical Trial
Date:5/7/2011

number of attributes that may provide clinically important advantages over several comparator products:

  • Eight to 16 times more potent than azithromycin and is active against organisms that have become resistant to azithromycin
  • Potent in vitro activity against all important respiratory pathogens, including pneumococci, beta-hemolytic streptococci, staphylococci, Hemophilus, Legionella, Mycoplasma, Moraxella and Chlamydophila
  • Potent in vitro activity against other medically significant pathogens, including CA-MRSA, M. avium, malaria, enterococci and gonococci
  • Good tolerability to date as demonstrated in Phase 1 trials of the oral formulation
  • Low resistance frequency in vitro
  • No inhibition of the acetylcholine nicotinic receptor, unlike telithromycin; such inhibition is believed responsible for certain adverse effects observed with telithromycin (Ketek®).
  • Excellent tissue distribution and intracellular tissue concentrations, including lung epithelial lining fluid and alveolar macrophages
  • Oral and IV formulations concurrently in development
  • Once-daily dosing

Potential for indications beyond CABP, including urethritis and other urogenital infections, bioterrorism targets, malaria, M. avium infections and tuberculosis

About TAKSTA™

TAKSTA, (sodium fusidate) is a novel class of antibiotic with an established history of safety and efficacy outside the United States. TAKSTA is being developed as an NCE in the U.S. for ABSSSI. Clinical trials with TAKSTA employ a proprietary front-loading oral regimen designed to increase potency, increase coverage and minimize resistance development. Cempra believes that TAKSTA will be an important addition to anti-MRSA therapies based on the following:

  • Sodium fusidate is orally active against gr
    '/>"/>

SOURCE Cempra Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol
2. New Model Provides Insights Into Intravenous and Subcutaneous Immunoglobulin Pharmacokinetics in Patients With Primary Immunodeficiencies
3. Jennerex and Transgene Announce Initiation of Clinical Trial of Intravenous JX-594 in Patients With Refractory Metastatic Colorectal Cancer
4. Reportlinker Adds Global Intravenous (IV) Iron Drugs Industry
5. Hospira to Standardize Intravenous (I.V.) Administration Sets Portfolio to Non-DEHP
6. Reportlinker Adds Intravenous Equipment - A World Market Intelligence Report
7. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
8. Iontophoretic Drug Delivery System (IDDS) Containing Lidocaine and Epinephrine is Effective in Reducing Pain Associated With Insertion of an Intravenous Catheter in a Phase 2 Clinical Trial
9. Calixa Therapeutics Announces Positive Phase 1 Results for CXA-101, a Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-Pseudomonal Activity
10. Pivotal Phase III Data Confirm the Efficacy and Safety of Arpidas Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections
11. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014  Aptuit LLC announces ... Lafayette, Indiana , has enhanced its capabilities ... of small and large molecules, including biologic drugs, ... Bruker maXisPlus Q-TOF mass spectrometer. In ... CEO, Aptuit, said, "The expanded large molecule capability ...
(Date:8/21/2014)... , Aug. 21, 2014   Memorial Hermann Health System ... Center today announced a new partnership to provide a ... community breast care centers in the greater Houston ... Anderson will become the exclusive provider of professional breast radiology ... located in Memorial City, The Woodlands , ...
(Date:8/21/2014)... 21, 2014  Vermillion, Inc. (NASDAQ: VRML ... and women,s health, has appointed Holly B. Bauzon ... Ms. Bauzon has a proven track record ... for laboratory services companies. She has more than 20 ... where she held the position of Director, Lab Services ...
Breaking Medicine Technology:Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2
... 25, 2007 /PRNewswire-FirstCall/ --,Genaera Corporation today announced ... (MSI-1436) for the treatment of obesity were,presented ... Sessions, June 22-25 in Chicago, IL. Dr. ... of Abstract #1801-P,presented, "Trodusquemine is a Multiple ...
... 25, 2007 - Gilead,Sciences, Inc. (Nasdaq:GILD) today ... trial evaluating the company's once-daily,anti-HIV drug Viread(R) ... as a potential treatment for chronic hepatitis ... endpoint. The data show,that Viread is non-inferior ...
Cached Medicine Technology:Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 2Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 3Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6
(Date:8/22/2014)... The rising numbers of teen drug and ... NC. For many years, countless lives have been lost due ... the community a new helpline was established to provide a ... Carolina who are seeking to overcome their addiction issues. ... 348-5762, parents and their teens can speak immediately to a ...
(Date:8/22/2014)... Teen substance abuse has long been a major ... of young adults falling victim to a drug or ... difference in the community, the new Troubled Teens Toledo helpline ... to overcome their chemical dependency. The helpline is designed to ... center to focus on achieving sobriety. , By contacting the ...
(Date:8/22/2014)... Teen substance abuse has long been major issue ... adults never receive the professional treatment they need. To ... Troubled Teens Columbus helpline was established to provide a ... and alcohol dependencies . , By calling ... can speak directly to a representative who can offer ...
(Date:8/22/2014)... Dealing with a drug or alcohol addiction is never ... child. Adolescent substance abuse has been an important issue among ... new helpline is now providing a valuable resource for teens ... like a teen drug addiction . , The ... positive impact in the community. By calling (513) 318-1603, parents ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Drug and ... Ohio. Over the years, substance abuse has claimed thousands ... in Brunswick, OH is providing hope for teenagers who ... Teens Brunswick helpline is designed to provide adolescents and ... where to find the best youth rehab facility to ...
Breaking Medicine News(10 mins):Health News:Troubled Teens in Asheville, NC Turn to Helpline for Valuable Assistance 2Health News:New Helpline Provides Hope for Troubled Teens in Toledo 2Health News:New Helpline in Columbus Assists Troubled Teen Find Youth Rehab 2Health News:Cincinnati’s New Troubled Teen Helpline is Making a Difference in the Community 2Health News:Substance Abuse Helpline Provides Hope for Teens & Parents in Brunswick, OH 2
... residents,neuroscience researchers, and interested clinicians will each have,opportunities ... of stroke during the Texas Brain and Spine ... year,s symposium will consist of a,morning presentation for ... researchers. The speakers are both neuroscience specialists who ...
... online community, for people who support affordable health insurance options ... ... While politicians dispense,their health care ideas at party conventions and ... common place to do so is at,AffordableHealthInsurance.NET -- a new social ...
... Lance Armstrong, cancer,survivor, founder and chairman of the Lance ... regarding his return to,professional sports:, "I am happy ... family,and my closest friends, I have decided to return ... global cancer burden. This year alone,nearly eight million people ...
... Pa., Sept. 9 Encorium Group, Inc.,(Nasdaq: ... organization,(CRO) conducting studies in over 30 countries for ... today announced that it,has entered into an amendment ... Research International, Inc. ("Prologue"). Pursuant to the,Amendment, the ...
... women between the ages of 40 and 59 could substantially ... in the September 9 online issue of the Journal ... programs are regularly used in developed countries where the incidence ... system is in place. The value and practicality of such ...
... A narrow region on chromosome 15 contains genetic variations ... conducted by scientists at Washington University School of Medicine ... States and the United Kingdom. , The researchers found ... cancer for people who have both a family history ...
Cached Medicine News:Health News:Texas Brain and Spine Institute to Hold Second Annual Neuroscience Symposium 2Health News:Social Network for Affordable Health Care Supporters Stimulates a New Level of Interactivity and Dialogue 2Health News:Prologue Acquisition Update and Termination of Linkcon Business Combination 2Health News:Prologue Acquisition Update and Termination of Linkcon Business Combination 3Health News:Prologue Acquisition Update and Termination of Linkcon Business Combination 4Health News:Prologue Acquisition Update and Termination of Linkcon Business Combination 5Health News:Breast cancer screening may lower mortality and disease burden in India 2Health News:Genetic region linked to a 5 times higher lung cancer risk 2Health News:Genetic region linked to a 5 times higher lung cancer risk 3
... engineered to set a new standard for ... enter the patient demographics, select auto report ... based system uses the latest in software ... of the IQmark Holter algorithm. Simple, intuitive ...
... your patients' remarkable skin Transformation in less than ... common alpha-hydroxy peels or other superficial procedures, the ... hands - yours. Based on your patients' particular ... of Tricloracetic Acid (TCA) peels and number of ...
... Smoothie is deliciously refreshing scrub ... the use of a gentle ... exfoliate the skin to restore ... irritation. This light chemical peel ...
... rapid exfoliator. Lactic Acid is is recommended for ... agents in skin care products, as well as ... long period and want to improve results. ,Lactic ... combined with the chemical free style of Peel ...
Medicine Products: